deltatrials
Recruiting OBSERVATIONAL NCT04864171

REASSURE-NIRS Registry (REASSURENIRS)

REvelation of PAthophySiological PhenotypeS of VUlneRable Lipid-Rich PlaquE on Near-InfraRed Spectroscopy: REASSURE-NIRS

Sponsor: National Cerebral and Cardiovascular Center, Japan

Updated 7 times since 2021 Last updated: Aug 12, 2025 Started: Oct 9, 2018 Primary completion: Dec 31, 2028 Completion: Mar 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Lipid-Rich Atherosclerosis of Coronary Artery, this trial is actively recruiting participants. The trial is conducted by National Cerebral and Cardiovascular Center, Japan and has accumulated 7 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~May 2021 – ~Dec 2022 · 19 months · monthly snapshotRecruiting~Dec 2022 – ~Nov 2023 · 11 months · monthly snapshotRecruiting~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~May 2025 · 8 months · monthly snapshotRecruiting~May 2025 – ~Sep 2025 · 4 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting

    Status: UnknownRecruiting

  2. May 2025 — Sep 2025 [monthly]

    Unknown

    Status: RecruitingUnknown

  3. Sep 2024 — May 2025 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. Nov 2023 — Jul 2024 [monthly]

    Recruiting

Show 2 earlier versions
  1. Dec 2022 — Nov 2023 [monthly]

    Recruiting

  2. May 2021 — Dec 2022 [monthly]

    Recruiting

    First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cerebral and Cardiovascular Center, Japan
Data source: National Cerebral and Cardiovascular Center, Japan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations